Immune deficiency or hyperactivity-Nf-κb illuminates autoimmunity

Journal of Autoimmunity

Volumn 31, Issue 3, 2008, Pages 245-251

  Pai, Saparna ^a   Thomas, Ranjeny ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Autoimmunity; NF kappa B; Rheumatoid arthritis; Tolerance; Type 1 diabetes

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL SURVIVAL; HYPERACTIVITY; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHATIC SYSTEM; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; IMMUNE TOLERANCE; IMMUNITY, ACTIVE; IMMUNITY, INNATE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 56649112944     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.04.012     Document Type: Article

References (68)

1. Moynagh P.N. The NF-kappaB pathway. J Cell Sci 118 (2005) 4589-4592
2. Doyle S.L., and O'Neill L.A. Toll-like receptors: from the discovery of NF-kappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72 (2006) 1102-1113
3. O'Sullivan B., Thompson A.G., and Thomas R. NF-kappaB as a therapeutic target in autoimmune disease. Expert Opin Ther Targets 11 (2007) 111-122
4. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
5. Hoffmann A., and Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev 210 (2006) 171-186
6. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl. (2002) S81-S96
7. Huang T.T., Kudo N., Yoshida M., and Miyamoto S. A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci U S A 97 (2000) 1014-1019
8. Yamamoto Y., and Gaynor R.B. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci 29 (2004) 72-79
9. Xiao G., Rabson A.B., Young W., Qing G., and Qu Z. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 17 (2006) 281-293
10. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17 (2002) 525-535
11. Saccani S., Pantano S., and Natoli G. Modulation of NF-kappaB activity by exchange of dimers. Mol Cell 11 (2003) 1563-1574
12. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 3 (2002) 958-965
13. Martin M.U., and Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 1592 (2002) 265-280
14. Janssens S., and Beyaert R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem Sci 27 (2002) 474-482
15. Thomas R. The TRAF6-NF-kappaB signaling pathway in autoimmunity: not just inflammation. Arthritis Res Ther 7 (2005) 170-173
16. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., and Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappaB. Nature 376 (1995) 167-170
17. Schmidt-Supprian M., Tian J., Ji H., Terhorst C., Bhan A.K., Grant E.P., et al. I kappa B kinase 2 deficiency in T cells leads to defects in priming, B cell help, germinal center reactions, and homeostatic expansion. J Immunol 173 (2004) 1612-1619
18. Banerjee D., Liou H.C., and Sen R. c-Rel-dependent priming of naive T cells by inflammatory cytokines. Immunity 23 (2005) 445-458
19. Sha W.C., Liou H.C., Tuomanen E.I., and Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80 (1995) 321-330
20. Kinoshita D., Hirota F., Kaisho T., Kasai M., Izumi K., Bando Y., et al. Essential role of IkappaB kinase alpha in thymic organogenesis required for the establishment of self-tolerance. J Immunol 176 (2006) 3995-4002
21. Karp C.L., Wysocka M., Ma X., Marovich M., Factor R.E., Nutman T., et al. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol 28 (1998) 3128-3136
22. LeibundGut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8 (2007) 630-638
23. Nolte M.A., Leibundgut-Landmann S., Joffre O., and Reis e Sousa C. Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo. J Exp Med 204 (2007) 1487-1501
24. + regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci U S A 101 (2004) 4566-4571
25. Kappler J.W., Roehm N., and Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 49 (1987) 273-280
26. Bonasio R., Scimone M.L., Schaerli P., Grabie N., Lichtman A.H., and von Andrian U.H. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 7 (2006) 1092-1100
27. Mathis D., and Benoist C. A decade of AIRE. Nat Rev Immunol 7 (2007) 645-650
28. O'Garra A., and Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 10 (2004) 801-805
29. + T cells. J Immunol 178 (2007) 2094-2103
30. + dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J Immunol 175 (2005) 196-200
31. Martin E., Capini C., Duggan E., Lutzky V.P., Stumbles P., Pettit A.R., et al. Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB. Arthritis Rheum 56 (2007) 2255-2266
32. Moore F., Buonocore S., Aksoy E., Ouled-Haddou N., Goriely S., Lazarova E., et al. An alternative pathway of NF-kappaB activation results in maturation and T cell priming activity of dendritic cells overexpressing a mutated IkappaBalpha. J Immunol 178 (2007) 1301-1311
33. Martin E., O'Sullivan B., Low P., and Thomas R. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 18 (2003) 155-167
34. O'Sullivan B., and Thomas R. CD40 and dendritic cell function. Crit Rev Immunol 23 (2003) 83-107
35. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
36. Fehervari Z., Yamaguchi T., and Sakaguchi S. The dichotomous role of IL-2: tolerance versus immunity. Trends Immunol 27 (2006) 109-111
37. + regulatory T cells by antigen-processing dendritic cells. J Exp Med 198 (2003) 235-247
38. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204 (2007) 1757-1764
39. Yoshitomi H., Sakaguchi N., Kobayashi K., Brown G.D., Tagami T., Sakihama T., et al. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 201 (2005) 949-960
40. Weih F., Durham S.K., Barton D.S., Sha W.C., Baltimore D., and Bravo R. Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent. J Immunol 157 (1996) 3974-3979
41. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., and Tree T.I. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54 (2005) 92-99
42. Adriani M., Aoki J., Horai R., Thornton A.M., Konno A., Kirby M., et al. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin Immunol 124 (2007) 41-48
43. + T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 56 (2007) 2080-2091
44. Handel M.L., McMorrow L.B., and Gravallese E.M. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum 38 (1995) 1762-1770
45. Marok R., Winyard P.G., Coumbe A., Kus M.L., Gaffney K., Blades S., et al. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum 39 (1996) 583-591
46. Pettit A.R., MacDonald K.P.A., O'Sullivan B., and Thomas R. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum 43 (2000) 791-800
47. + cells are found in normal lymphoid organs and in peripheral tissue in the context of inflammation, but not under normal resting conditions. Immunol Cell Biol 80 (2002) 164-169
48. Ludewig B., Odermatt B., Ochsenbein A.F., Zinkernagel R.M., and Hengartner H. Role of dendritic cells in the induction and maintenance of autoimmune diseases. Immunol Rev 169 (1999) 45-54
49. Leung B.P., Conacher M., Hunter D., McInnes I.B., Liew F.Y., and Brewer J.M. A novel dendritic cell-induced model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction of local inflammation. J Immunol 169 (2002) 7071-7077
50. Thomas R., and Lipsky P.E. Presentation of self-peptides by dendritic cells. Possible implications for the pathogenesis of rheumatoid arthritis. Arthritis Rheum 39 (1996) 183-190
51. Cavanagh L.L., Boyce A., Smith L., Padmanabha J., Filgueira L., Pietschmann P., et al. Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther 7 (2005) R230-R240
52. Kawane K., Ohtani M., Miwa K., Kizawa T., Kanbara Y., Yoshioka Y., et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443 (2006) 998-1002
53. Paleolog E.M., Hunt M., Elliott M.J., Feldmann M., Maini R.N., and Woody J.N. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis. Arthritis Rheum 39 (1996) 1082-1091
54. Pai S., O'Sullivan B., Abdul-Jabbar I., Peng J., Connoly G., Khanna R., et al. Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function. Immunol Cell Biol 85 (2007) 370-377
55. Balandraud N., Roudier J., and Roudier C. Epstein-Barr virus and rheumatoid arthritis. Autoimmun Rev 3 (2004) 362-367
56. Han Z., Boyle D.L., Manning A.M., and Firestein G.S. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28 (1998) 197-208
57. Kraan M.C., Versendaal H., Jonker M., Bresnihan B., Post W.J., t Hart B.A., et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 41 (1998) 1481-1488
58. Campbell I.K., Gerondakis S., O'Donnell K., and Wicks I.P. Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest 105 (2000) 1799-1806
59. Bondeson J., Foxwell B., Brennan F., and Feldmann M. Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci U S A 96 (1999) 5668-5673
60. Tak P.P., Gerlag D.M., Aupperle K.R., van de Geest D.A., Overbeek M., Bennett B.L., et al. Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum 44 (2001) 1897-1907
61. Seetharaman R., Mora A.L., Nabozny G., Boothby M., and Chen J. Essential role of T cell NF-kappa B activation in collagen-induced arthritis. J Immunol 163 (1999) 1577-1583
62. Jansen A., van Hagen M., and Drexhage H.A. Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 345 (1995) 491-492
63. Vuckovic S., Withers G., Harris M., Khalil D., Gardiner D., Flesch I., et al. Decreased blood dendritic cell counts in type 1 diabetic children. Clin Immunol 123 (2007) 281-288
64. Mollah Z.U.A., Pai S., Moore C., O'Sullivan B.J., Harrison M.J., Peng J., et al. Abnormal NF-kappa B function characterizes human type 1 diabetes dendritic cells and monocytes. J Immunol 180 (2008) 3166-3175
65. Devaraj S., Dasu M.R., Rockwood J., Winter W., Griffen S.C., and Jialal I. Increased toll-like receptor (TLR) 2 and TLR-4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 93 (2008) 578-583
66. Wang X., Jia S., Geoffrey R., Alemzadeh R., Ghosh S., and Hessner M.J. Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol 180 (2008) 1929-1937
67. + effector T cells. J Immunol 176 (2006) 7278-7287
68. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446 (2007) 557-561